Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
66.20    -1.80 (-2.65%)
Bid:
65.90
Ask:
66.70
Spread: 0.80 (1.214%)
Market Cap: £584.83m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director Declaration

26 Jun 2023 12:41

RNS Number : 9289D
IP Group PLC
26 June 2023
 

FOR RELEASE ON

26 JUNE 2023

 

Director Declaration

IP Group plc (LSE: IPO) ("the Group"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, confirms that Heejae Chae, a non-executive director of the Group, has been appointed as executive chairman of SysGroup plc. This disclosure is made in accordance with LR 9.6.14R of the Listing Rules.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

Portland

Vic Wallin

Alex Donaldson

+44 (0) 7973 823119

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNNKABQDBKDKAB
Date   Source Headline
26th May 20207:00 amRNSOxford Nanopore announces £48.4m of new funding
22nd May 20207:00 amRNSOxford Nanopore in development of covid19 test
21st May 20207:00 amRNSIP Group sells 12.25m shares in Ceres Power
21st May 20207:00 amRNSResult of secondary placing in Ceres Power
20th May 20204:48 pmRNSProposed secondary placing in Ceres Power Holdings
19th May 202012:02 pmRNSPrice Monitoring Extension
15th May 20204:36 pmRNSPrice Monitoring Extension
13th May 202012:08 pmRNSSecond Price Monitoring Extn
13th May 202012:03 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSFeaturespace completes £30m funding round
12th May 202012:02 pmRNSPrice Monitoring Extension
7th May 202012:02 pmRNSPrice Monitoring Extension
29th Apr 20204:57 pmRNSHolding(s) in Company
24th Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20203:45 pmRNSNotice of AGM
8th Apr 20205:04 pmRNSHolding(s) in Company
6th Apr 20205:45 pmRNSHolding(s) in Company
30th Mar 20202:12 pmRNSIssue of Equity
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20209:00 amRNSHolding(s) in Company
11th Mar 20207:01 amRNSDirectorate Change
11th Mar 20207:00 amRNSFinal Results
23rd Jan 20202:46 pmRNSHolding(s) in Company
22nd Jan 20205:12 pmRNSHolding(s) in Company
22nd Jan 202012:46 pmRNSBosch to increase holding in Ceres Power to c18%
17th Jan 20204:07 pmRNSHolding(s) in Company
3rd Jan 20202:18 pmRNSForm 8.3 - Hvivo plc
2nd Jan 20207:00 amRNSOxford Nanopore completes £109.5m financing
19th Dec 20197:00 amRNSDirector Declaration
17th Dec 20194:50 pmRNSShare Capital Reduction Effective
12th Dec 201910:52 amRNSHolding(s) in Company
10th Dec 20191:12 pmRNSOxford Nanopore selected as sequencing partner
4th Dec 20194:10 pmRNSHolding(s) in Company
28th Nov 20194:10 pmRNSHolding(s) in Company
26th Nov 201911:24 amRNSHolding(s) in Company
25th Nov 20191:59 pmRNSResult of General Meeting
22nd Nov 20195:51 pmRNSHolding(s) in Company
11th Nov 20197:00 amRNSHolding(s) in Company
8th Nov 201912:02 pmRNSNotice of GM
30th Oct 20196:16 pmRNSHolding(s) in Company
28th Oct 20196:06 pmRNSHolding(s) in Company
9th Oct 201910:22 amRNSHolding(s) in Company
8th Oct 20196:08 pmRNSSAYE scheme
2nd Oct 20195:24 pmRNSHolding(s) in Company
2nd Oct 20195:18 pmRNSHolding(s) in Company
27th Sep 20195:58 pmRNSHolding(s) in Company
26th Sep 20195:44 pmRNSHolding(s) in Company
26th Sep 20195:12 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSHalf-yearly results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.